TTP enhances the sensitivity of KRASG12C-mutated lung cancer cells to KRASG12C inhibitors by downregulating SLC7A11 and promoting ferroptosis. - Park KR; Le MX; Sul OJ; Jeon J; Kwon MS; Lee H; Ra SW; Kwon HN; Cho WJ; Park JW (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2025)